Basic Information
| RNALocate ID: | RLID:11004956 |
| RNA Symbol: | hsa-miR-1307-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-1307-5p |
| RNA ID: | miRBase:MIMAT0022727 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 25330373 |
| Tissue/Cell Line: | Colon cancer cell line (LIM1863) |
| Method: | qRT-PCR|RNA sequencing |
| Description: | To assess whether some miRNAs are specifically sorted into EVs we conducted a miRNA-enrichment analysis for A33-Exos, EpCAM-Exos and sMVs. MiRNAs with <2 fold changes relative to CL miRNAs were filtered out, yielding 63 miRNAs for comparison (Table 2). Data are collected from Table 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11004955 | Exosome | Plasma | 23663360 |
| RLID:11004957 | Microvesicle | Serum | 24797360 |
| RLID-D:11000251 | Exosome | Blood|B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Endothelial cells|Kidney tissue|Lymphoma tissue | |
| RLID-D:11001044 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-1307-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-10512 |
| MNDR | hsa-miR-1307-5p | Gastric cancer | MNDR-E-MI-10513 |
| MNDR | hsa-miR-1307-5p | Alzheimer disease | MNDR-E-MI-10514 |
| MNDR | hsa-miR-1307-5p | Polycystic ovary syndrome | MNDR-E-MI-10515 |
| MNDR | hsa-miR-1307-5p | Cardiovascular disease | MNDR-E-MI-10516 |
| MNDR | hsa-miR-1307-5p | Parkinson disease | MNDR-E-MI-10517 |
| MNDR | hsa-miR-1307-5p | Rectum adenocarcinoma | MNDR-E-MI-10518 |
| MNDR | hsa-miR-1307-5p | Colon adenocarcinoma | MNDR-E-MI-10519 |
| MNDR | hsa-miR-1307-5p | Prostate adenocarcinoma | MNDR-E-MI-10520 |
| MNDR | hsa-miR-1307-5p | Carcinoma ductal breast | MNDR-E-MI-10521 |
| MNDR | hsa-miR-1307-5p | Glioblastoma | MNDR-E-MI-10522 |
| MNDR | hsa-miR-1307-5p | Breast carcinoma | MNDR-E-MI-10523 |
| MNDR | hsa-miR-1307-5p | Gastric adenocarcinoma | MNDR-E-MI-10524 |
| MNDR | hsa-miR-1307-5p | Cervical squamous cell carcinoma | MNDR-E-MI-10525 |
| MNDR | hsa-miR-1307-5p | Lung squamous cell carcinoma | MNDR-E-MI-10526 |
| MNDR | hsa-miR-1307-5p | Lung adenocarcinoma | MNDR-E-MI-10527 |
| MNDR | hsa-miR-1307-5p | Thyroid carcinoma | MNDR-E-MI-10528 |
| MNDR | hsa-miR-1307-5p | Bladder urothelial carcinoma | MNDR-E-MI-10529 |
| MNDR | hsa-miR-1307-5p | Carcinoma renal cell | MNDR-E-MI-10530 |
| MNDR | hsa-miR-1307-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-10531 |
| MNDR | hsa-miR-1307-5p | Renal clear cell carcinoma | MNDR-E-MI-10532 |
| MNDR | hsa-miR-1307-5p | Liver cirrhosis | MNDR-E-MI-10533 |
| MNDR | hsa-miR-1307-5p | Breast invasive carcinoma | MNDR-E-MI-10534 |
| MNDR | hsa-miR-1307-5p | Hepatocellular carcinoma | MNDR-E-MI-10535 |
| MNDR | hsa-miR-1307-5p | Rheumatoid arthritis | MNDR-E-MI-10536 |
| MNDR | hsa-miR-1307-5p | Skin cutaneous melanoma | MNDR-E-MI-10537 |
| MNDR | hsa-miR-1307-5p | Skin melanoma | MNDR-E-MI-10538 |
| MNDR | hsa-miR-1307-5p | Epstein-barr virus infections | MNDR-E-MI-10539 |
| MNDR | hsa-miR-1307-5p | Low grade dysplastic nodule | MNDR-E-MI-10540 |
TOP